There is a magic bullet for some cancers, but it's not a slam-dunk

'What you don't want to do is use therapy where it brings no value to patients, adds to cost and doesn't lead to better results,' said Joseph Alvarnas, a hematologist oncologist at City of Hope in Dua

Shahzad Bhat, 53, was working at the MGM Mansion in Las Vegas when his doctor gave him three months to live in October 2017. There were no more treatments available for his aggressive form of lymphoma.

Like some of the elite gamblers who stayed at the casino, Bhat got lucky. A day before his appointment, an experimental cancer drug from Gilead Sciences Inc. had been approved in the U.S. Bhat become one of the first people to get the breakthrough therapy, Yescarta, after its approval, and his cancer went in remission quickly.“It was a miracle,” said his wife, Nicole Bhat. “He